PHAT Return on Tangible Equity | PHATHOM PHARMACEUTICALS, INC.

PHATHOM PHARMACEUTICALS, INC. (PHAT) Return on Tangible Equity

2026-06-30: Return Tang Equity 28.78%.
2026-03-31: Return Tang Equity 46.68%.
2025-12-31: Return Tang Equity 50.49%.
2025-09-30: Return Tang Equity 64.98%.

Complete source-backed return tang equity history.

Available history: 2018-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	28.78%
2026-03-31	46.68%
2025-12-31	50.49%
2025-09-30	64.98%
2025-06-30	81.35%
2025-03-31	102.19%
2024-12-31	131.84%
2024-09-30	181.41%
2024-06-30	127.06%
2024-03-31	166.08%
2023-12-31	277.07%
2023-09-30	996.28%
2023-06-30	-1050.66%
2023-03-31	216.06%
2022-12-31	264.29%
2022-09-30	675.56%
2022-06-30	2343.90%
2022-03-31	-393.60%
2021-12-31	-199.41%
2021-09-30	-156.34%
2021-06-30	-120.51%
2021-03-31	-87.48%
2020-12-31	-66.44%
2020-09-30	-110.85%
2020-06-30	-110.05%
2020-03-31	-131.30%
2019-12-31	-111.92%
2019-09-30	103.38%
2019-06-30	106.40%
2019-03-31	90.07%
2018-12-31	100.16%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	50.49%
2024-12-31	131.84%
2023-12-31	277.07%
2022-12-31	264.29%
2021-12-31	-199.41%
2020-12-31	-66.44%
2019-12-31	-111.92%
2018-12-31	100.16%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Altimmune, Inc. (ALT)	United States	$0.593B	-6.43
Monopar Therapeutics (MNPR)	United States	$0.598B	-34.82
CytomX Therapeutics, Inc. (CTMX)	United States	$0.598B	-10.25
CorMedix Inc. (CRMD)	United States	$0.605B	3.25
Aquestive Therapeutics, Inc. (AQST)	United States	$0.606B	-6.67
Indaptus Therapeutics, Inc. (INDP)	United States	$0.537B
IMPACT BIOMEDICAL INC. (IBO)	United States	$0.611B	66.47
CRESCENT BIOPHARMA, INC. (CBIO)	United States	$0.529B	-5.20
Evolus, Inc. (EOLS)	United States	$0.519B	-13.32
Neurogene Inc. (NGNE)		$0.625B	-4.46